Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Novo Nordisk's Victoza (liraglutide)

Victoza data shows promise for early setting

September 13, 2011 Research and Development, Sales and Marketing Novo Nordisk, Victoza

New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …
News
Shanghai China flag

Betting big on research in China

September 13, 2011 Manufacturing and Production, Research and Development China, R&D

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …
Feature

AM-Pharma appoints new chief executive

September 13, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dutch biopharmaceutical company AM-Pharma has appointed Erik van den Berg as its new chief executive. He was previously VP business …
Appointment

GSK scales back breast cancer trial

September 12, 2011 Research and Development, Sales and Marketing GSK, Tyverb

GSK has halted one of the four phase III studies that make up the ALTTO programme for its cancer drug …
News

Takeda moves potential first-in-class diabetes drug into phase III

September 12, 2011 Research and Development, Sales and Marketing TAK-875, Takeda, diabetes

Takeda has moved its potential first-in-class diabetes candidate TAK-875 into phase III clinical trials. The company hopes TAK-875 will offer …
News

New ABPI chief executive to focus on industry reputation

September 8, 2011 Research and Development, Sales and Marketing ABPI, industry relations

The new chief executive of the ABPI used his first public speech to focus on the reputation of the pharma …
News

Algeta appoints first head of comms and investor relations

September 8, 2011 Medical Communications, Research and Development appointment, medical communications, research and development

Norwegian biotech Algeta has appointed Dr Mike Booth to the newly-created role of senior VP of communications and corporate affairs. …
Appointment

Clinical research news in brief

September 8, 2011 Research and Development research and development news

This roundup includes using social media to recruit trial subjects, a strategic level service deal between BMS and Icon, plus …
News

Eisai shares risk with novel trial funding approach

September 7, 2011 Research and Development Eisai, clinical trials, research and development news

Eisai has unveiled a novel risk-sharing approach to accelerate its late-stage research programme by accepting new sources of clinical trial …
News
EMA

EMA should compare ‘like-for-like’ when assessing new drugs

September 7, 2011 Research and Development EMA, clnical trials, research and development news

The European system of comparing drugs against placebo and not against a comparator is flawed, according to a new LSE …
News

Lilly considering a stake in Turkish drugmaker

September 6, 2011 Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …
News

Zonegran study could pave way for paediatric licence

September 2, 2011 Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news

Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …
News
Pfizer Sandwich Kent

Ex-Pfizer employees set up new business at Sandwich

September 1, 2011 Research and Development Pfizer, Sandwich, The Research Network, research and development news

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …
News

Stem cell trial for stroke is safe

September 1, 2011 Research and Development ReNeuron, Stem cells, stroke

A pioneering stem cell treatment for patients who have suffered a stroke has been ruled safe, and can continue to …
News

Merck acquires cell imaging instrument maker Amnis

September 1, 2011 Research and Development Merck KGaA, Millipore

EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026